Búsqueda | Portal de Búsqueda de la BVS

1.

BNT162b2 vaccine induces neutralizing antibodies and poly-specific T cells in humans.

Sahin, Ugur; Muik, Alexander; Vogler, Isabel; Derhovanessian, Evelyna; Kranz, Lena M; Vormehr, Mathias; Quandt, Jasmin; Bidmon, Nicole; Ulges, Alexander; Baum, Alina; Pascal, Kristen E; Maurus, Daniel; Brachtendorf, Sebastian; Lörks, Verena; Sikorski, Julian; Koch, Peter; Hilker, Rolf; Becker, Dirk; Eller, Ann-Kathrin; Grützner, Jan; Tonigold, Manuel; Boesler, Carsten; Rosenbaum, Corinna; Heesen, Ludwig; Kühnle, Marie-Cristine; Poran, Asaf; Dong, Jesse Z; Luxemburger, Ulrich; Kemmer-Brück, Alexandra; Langer, David; Bexon, Martin; Bolte, Stefanie; Palanche, Tania; Schultz, Armin; Baumann, Sybille; Mahiny, Azita J; Boros, Gábor; Reinholz, Jonas; Szabó, Gábor T; Karikó, Katalin; Shi, Pei-Yong; Fontes-Garfias, Camila; Perez, John L; Cutler, Mark; Cooper, David; Kyratsous, Christos A; Dormitzer, Philip R; Jansen, Kathrin U; Türeci, Özlem.

Nature ; 595(7868): 572-577, 2021 07.

Artículo en Inglés | MEDLINE | ID: mdl-34044428

2.

COVID-19 vaccine BNT162b1 elicits human antibody and T_H1 T cell responses.

Sahin, Ugur; Muik, Alexander; Derhovanessian, Evelyna; Vogler, Isabel; Kranz, Lena M; Vormehr, Mathias; Baum, Alina; Pascal, Kristen; Quandt, Jasmin; Maurus, Daniel; Brachtendorf, Sebastian; Lörks, Verena; Sikorski, Julian; Hilker, Rolf; Becker, Dirk; Eller, Ann-Kathrin; Grützner, Jan; Boesler, Carsten; Rosenbaum, Corinna; Kühnle, Marie-Cristine; Luxemburger, Ulrich; Kemmer-Brück, Alexandra; Langer, David; Bexon, Martin; Bolte, Stefanie; Karikó, Katalin; Palanche, Tania; Fischer, Boris; Schultz, Armin; Shi, Pei-Yong; Fontes-Garfias, Camila; Perez, John L; Swanson, Kena A; Loschko, Jakob; Scully, Ingrid L; Cutler, Mark; Kalina, Warren; Kyratsous, Christos A; Cooper, David; Dormitzer, Philip R; Jansen, Kathrin U; Türeci, Özlem.

Nature ; 586(7830): 594-599, 2020 10.

Artículo en Inglés | MEDLINE | ID: mdl-32998157

3.

Publisher Correction: COVID-19 vaccine BNT162b1 elicits human antibody and T_H1 T cell responses.

Sahin, Ugur; Muik, Alexander; Derhovanessian, Evelyna; Vogler, Isabel; Kranz, Lena M; Vormehr, Mathias; Baum, Alina; Pascal, Kristen; Quandt, Jasmin; Maurus, Daniel; Brachtendorf, Sebastian; Lörks, Verena; Sikorski, Julian; Hilker, Rolf; Becker, Dirk; Eller, Ann-Kathrin; Grützner, Jan; Boesler, Carsten; Rosenbaum, Corinna; Kühnle, Marie-Cristine; Luxemburger, Ulrich; Kemmer-Brück, Alexandra; Langer, David; Bexon, Martin; Bolte, Stefanie; Karikó, Katalin; Palanche, Tania; Fischer, Boris; Schultz, Armin; Shi, Pei-Yong; Fontes-Garfias, Camila; Perez, John L; Swanson, Kena A; Loschko, Jakob; Scully, Ingrid L; Cutler, Mark; Kalina, Warren; Kyratsous, Christos A; Cooper, David; Dormitzer, Philip R; Jansen, Kathrin U; Türeci, Özlem.

Nature ; 590(7844): E17, 2021 Feb.

Artículo en Inglés | MEDLINE | ID: mdl-33469214

4.

Midazolam microdosing applied in early clinical development for drug-drug interaction assessment.

Wiebe, Sabrina T; Huennemeyer, Andreas; Kadus, Werner; Goettel, Markus; Jambrecina, Alen; Schultz, Armin; Vinisko, Richard; Schlieker, Laura; Herich, Lena; Mikus, Gerd.

Br J Clin Pharmacol ; 87(1): 178-188, 2021 01.

Artículo en Inglés | MEDLINE | ID: mdl-32436239

5.

Safety, pharmacokinetics and pharmacodynamics of BI 705564, a highly selective, covalent inhibitor of Bruton's tyrosine kinase, in Phase I clinical trials in healthy volunteers.

Litzenburger, Tobias; Steffgen, Jürgen; Benediktus, Ewald; Müller, Fabian; Schultz, Armin; Klein, Elliott; Ramanujam, Meera; Harcken, Christian; Gupta, Alpana; Wu, Jing; Wiebe, Sabrina; Li, Xiujiang; Flack, Mary; Padula, Steven J; Visvanathan, Sudha; Hünnemeyer, Andreas; Hui, Jianan.

Br J Clin Pharmacol ; 87(4): 1824-1838, 2021 04.

Artículo en Inglés | MEDLINE | ID: mdl-32986868

6.

Bioequivalence of macitentan and tadalafil given as fixed-dose combination or single-component tablets in healthy subjects.

Grill, Simon; Bruderer, Shirin; Sidharta, Patricia N; Antonova, Mariya; Globig, Susanne; Carlson, James; Schultz, Armin; Csonka, Dénes.

Br J Clin Pharmacol ; 86(12): 2424-2434, 2020 12.

Artículo en Inglés | MEDLINE | ID: mdl-32374030

7.

Challenges in the Development of Intravenous Neurokinin-1 Receptor Antagonists: Results of a Safety and Pharmacokinetics Dose-Finding, Phase 1 Study of Intravenous Fosnetupitant.

Tyler, Timothy; Schultz, Armin; Venturini, Alessio; Giuliano, Claudio; Bernareggi, Alberto; Spezia, Riccardo; Voisin, Daniel; Stella, Valentino.

Clin Pharmacol Drug Dev ; 11(12): 1405-1418, 2022 12.

Artículo en Inglés | MEDLINE | ID: mdl-36263927

8.

Pharmacokinetics, Safety, and Tolerability of the α_2C -Adrenoreceptor Antagonist BAY 1193397 in Healthy Male Subjects.

Kapsa, Stefanie; Thuss, Uwe; Boxnick, Stefanie; Schaumann, Frank; Schultz, Armin; Unger, Sigrun; Otto, Christiane.

Clin Pharmacol Drug Dev ; 11(3): 296-308, 2022 03.

Artículo en Inglés | MEDLINE | ID: mdl-34464517

9.

Phase I studies of BI 1015550, a preferential phosphodiesterase 4B inhibitor, in healthy males and patients with idiopathic pulmonary fibrosis.

Maher, Toby M; Schlecker, Christina; Luedtke, Doreen; Bossert, Sebastian; Zoz, Donald F; Schultz, Armin.

ERJ Open Res ; 8(4)2022 Oct.

Artículo en Inglés | MEDLINE | ID: mdl-36299369

10.

Dalteparin dose-dependently increases ROTEM(®) thrombelastography parameters only at supratherapeutic anti-factor Xa levels: an in vitro study.

Feuring, Martin; Wehling, Martin; Schultz, Armin.

Clin Exp Pharmacol Physiol ; 38(11): 783-6, 2011 Nov.

Artículo en Inglés | MEDLINE | ID: mdl-21883380

11.

Pharmacokinetics, Safety, and Tolerability of the Novel Chymase Inhibitor BAY 1142524 in Healthy Male Volunteers.

Kanefendt, Friederike; Thuß, Uwe; Becka, Michael; Boxnick, Stefanie; Berse, Matthias; Schultz, Armin; Otto, Christiane.

Clin Pharmacol Drug Dev ; 8(4): 467-479, 2019 05.

Artículo en Inglés | MEDLINE | ID: mdl-29878583

12.

Effect of Macitentan on the Pharmacokinetics of the Breast Cancer Resistance Protein Substrates, Rosuvastatin and Riociguat, in Healthy Male Subjects.

Csonka, Dénes; Bruderer, Shirin; Schultz, Armin; Soergel, Marianne; Stepanova, Radka; Sabattini, Giancarlo; Perez-Ruixo, Juan Jose.

Clin Drug Investig ; 39(12): 1223-1232, 2019 Dec.

Artículo en Inglés | MEDLINE | ID: mdl-31552642

13.

Pharmacokinetic Interaction between Faldaprevir and Cyclosporine or Tacrolimus in Healthy Volunteers: A Prospective, Open-Label, Fixed-Sequence, Crossover Study.

Huang, Fenglei; Voelk, Claudia; Trampisch, Matthias; Rowland, Lois; Schultz, Armin; Sabo, John P.

Basic Clin Pharmacol Toxicol ; 123(1): 84-93, 2018 Jul.

Artículo en Inglés | MEDLINE | ID: mdl-29427400

14.

Multiple Rising Doses of Oral BI 425809, a GlyT1 Inhibitor, in Young and Elderly Healthy Volunteers: A Randomised, Double-Blind, Phase I Study Investigating Safety and Pharmacokinetics.

Moschetti, Viktoria; Schlecker, Christina; Wind, Sven; Goetz, Sophia; Schmitt, Holger; Schultz, Armin; Liesenfeld, Karl-Heinz; Wunderlich, Glen; Desch, Michael.

Clin Drug Investig ; 38(8): 737-750, 2018 Aug.

Artículo en Inglés | MEDLINE | ID: mdl-29846887

15.

To be or not to be (a receptor).

Wehling, Martin; Schultz, Armin; Lösel, Ralf.

Steroids ; 72(2): 107-10, 2007 Feb.

Artículo en Inglés | MEDLINE | ID: mdl-17234225

16.

Nongenomic actions of estrogens: exciting opportunities for pharmacology.

Wehling, Martin; Schultz, Armin; Lösel, Ralf.

Maturitas ; 54(4): 321-6, 2006 Jul 20.

Artículo en Inglés | MEDLINE | ID: mdl-16730139

17.

Effect of faldaprevir on raltegravir pharmacokinetics in healthy volunteers.

Joseph, David; Rose, Peter; Strelkowa, Natalja; Schultz, Armin; Garcia, Jeanette; Elgadi, Mabrouk; Huang, Fenglei.

J Clin Pharmacol ; 55(4): 384-91, 2015 Apr.

Artículo en Inglés | MEDLINE | ID: mdl-25352040

18.

Novel approaches in the treatment of allergic rhinitis.

Schultz, Armin; Stuck, Boris Alexander; Feuring, Martin; Hörmann, Karl; Wehling, Martin.

Curr Opin Allergy Clin Immunol ; 3(1): 21-7, 2003 Feb.

Artículo en Inglés | MEDLINE | ID: mdl-12582310

19.

A quick glance at rapid aldosterone action.

Lösel, Ralf; Schultz, Armin; Wehling, Martin.

Mol Cell Endocrinol ; 217(1-2): 137-41, 2004 Mar 31.

Artículo en Inglés | MEDLINE | ID: mdl-15134812

20.

The effects of modifying in vivo cytochrome P450 3A (CYP3A) activity on etoricoxib pharmacokinetics and of etoricoxib administration on CYP3A activity.

Agrawal, Nancy G B; Matthews, Catherine Z; Mazenko, Ralph S; Woolf, Eric J; Porras, Arturo G; Chen, Xun; Miller, Jutta L; Michiels, Nicole; Wehling, Martin; Schultz, Armin; Gottlieb, Alice B; Kraft, Walter K; Greenberg, Howard E; Waldman, Scott A; Curtis, Sean P; Gottesdiener, Keith M.

J Clin Pharmacol ; 44(10): 1125-31, 2004 Oct.

Artículo en Inglés | MEDLINE | ID: mdl-15342613

Portal de Búsqueda de la BVS

Información y Conocimiento para la Salud

Configurar filtros

Su selección (0)

Formato de exportación:

Exportar: